FDA Nominee Pushes Separate Conservative Science | Science News

Heidi Overton, President Trump’s pick to lead the FDA, is sparking controversy with her vision for a separate scientific infrastructure tailored to conservative ideas—calling for new journals and funding to counter what she claims is systemic bias against right-wing research. Her past role at a conservative think tank and resurfaced 2023 podcast remarks reveal deep frustration with mainstream institutions ignoring conservative perspectives. While the White House defends her as part of efforts to foster open discourse, critics warn this could politicize science, undermining its independence and threatening public health by tying evidence to ideology. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/02fbda038b8f8127